Sensodyne maker Haleon slips as sales growth concerns overshadow profit beat

By Raechel Thankam Job and Richa Naidu July 30 (Reuters) – Sluggish European demand and weak respiratory sales raised doubts on Thursday about whether Haleon can meet its sales targets, sending shares

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)